Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Roche:Genentech Integration Latest: Exclusive Interview on PharmaTelevision

Thu. June 04, 2009; Posted: 09:16 AM
Stocks RSS
Oxford, UK, Jun 04, 2009 (PRWeb.com via COMTEX) -- DNA | Quote | Chart | News | PowerRating -- PharmaTelevision (http://www.pharmatelelvision.com) announced today that it is to broadcast an exclusive interview with Dan Zabrowski, Global Head, Pharma Partnering, Roche Pharmaceuticals Division and Joe McCracken, Vice President, Business Development, Genentech, on the Roche:Genentech integration, on June 4th 2009.

The interview on the business TV show "PharmaVentures Business Review" reveals the new structure and position for Genentech in the Roche organisation and how companies wishing to partner with Roche or Genentech can do so in the future. The interview also discusses broader issues such as the future position of Genentech and its role moving forwards.

Dr Fintan Walton, CEO of PharmaVentures, who also presents the PharmaTelevision shows and interviewed both Zabrowski and McCracken, said: "This exclusive interview provides insight into the operations of one of the world's largest pharmaceutical companies. We are delighted that Roche used PharmaTelevision to communicate its integration strategy and how its implementation is progressing".

Notes to Editors: PharmaTelevision(R) (www.pharmatelevision.com) is the groundbreaking online TV channel for the pharmaceutical and biotech sector, offering insight and featured interviews with industry leaders every week. Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts over 200 TV programmes with a truly global audience, 60% of whom are C-suite executives. In 2008, the channel launched a sleek new look and introduced two exciting TV programmes - the Financial Report and the Regional Report, which, together with our well-established TV programmes, help to give our viewers a complete overview of industry trends, analysis including deals, investments and strategic policies within the sector. In 2009, PharmaTelevision will be launching PTV News - a daily summary and analysis of the major news headlines, ensuring that, wherever in the world they are, our audience can stay truly informed.

PharmaTelevision is a media division of PharmaVentures Ltd (www.pharmaventures.com).

For further information please contact: Fiona Bishop, +44 (0) 1865 784 187 or fiona(at)pharmatelevision.com

###

Read the full story at http://www.prweb.com/releases/pharmatelevision/roche/prweb2499074.htm.

PRWeb.com
For full details for DNA click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [DNA]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.